Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 9.0

(0.0%)

Operating Income Summary of Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.'s latest annual operating income in 2023 was 66.19 Million CNY , down -29.19% from previous year.
Charmacy Pharmaceutical Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 39.34 Million CNY , up 22.13% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported an annual operating income of 93.48 Million CNY in 2022, up 25.61% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported an annual operating income of 74.42 Million CNY in 2021, down -15.5% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly operating income of 51.75 Million CNY for 2023 Q2, up 5.64% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly operating income of 66.19 Million CNY for 2023 FY, down -29.19% from previous quarter.

Annual Operating Income Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Operating Income of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year	Operating Income	Operating Income Growth
2023	66.19 Million CNY	-29.19%
2022	93.48 Million CNY	25.61%
2021	74.42 Million CNY	-15.5%
2020	88.07 Million CNY	3.38%
2019	85.19 Million CNY	-14.01%
2018	99.08 Million CNY	18.35%
2017	83.71 Million CNY	0.31%
2016	83.45 Million CNY	-0.67%
2015	84.02 Million CNY	32.28%
2014	63.52 Million CNY	41.57%
2013	44.86 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	39.34 Million CNY	22.13%
2023 Q2	51.75 Million CNY	5.64%
2023 FY	66.19 Million CNY	-29.19%
2023 Q4	32.21 Million CNY	-37.77%
2022 FY	93.48 Million CNY	25.61%
2022 Q4	48.99 Million CNY	10.13%
2022 Q2	44.48 Million CNY	145.44%
2021 FY	74.42 Million CNY	-15.5%
2021 Q2	56.29 Million CNY	76.28%
2021 Q4	18.12 Million CNY	-67.8%
2020 Q4	31.93 Million CNY	-43.11%
2020 Q2	56.14 Million CNY	322.46%
2020 FY	88.07 Million CNY	3.38%
2019 Q4	13.28 Million CNY	-81.52%
2019 Q2	71.9 Million CNY	298.96%
2019 FY	85.19 Million CNY	-14.01%
2018 Q2	81.05 Million CNY	416.82%
2018 Q4	18.02 Million CNY	-77.76%
2018 FY	99.08 Million CNY	18.35%
2017 Q4	15.68 Million CNY	-76.95%
2017 FY	83.71 Million CNY	0.31%
2017 Q2	68.03 Million CNY	126.61%
2016 Q4	30.02 Million CNY	-43.82%
2016 Q2	53.43 Million CNY	28.48%
2016 FY	83.45 Million CNY	-0.67%
2015 Q2	42.43 Million CNY	81.49%
2015 FY	84.02 Million CNY	32.28%
2015 Q4	41.59 Million CNY	-1.99%
2014 FY	63.52 Million CNY	41.57%
2014 Q2	40.14 Million CNY	133.48%
2014 Q4	23.38 Million CNY	-41.75%
2013 FY	44.86 Million CNY	0.0%
2013 Q4	17.19 Million CNY	0.0%

Peer Operating Income Comparison of Charmacy Pharmaceutical Co., Ltd.

Name	Operating Income	Operating Income Difference
Wanjia Group Holdings Limited	-15.4 Million HKD	529.781%
China Health Group Limited	-36.11 Million HKD	283.304%
Tai United Holdings Limited	-344.16 Million HKD	119.233%